Electrospray and atmospheric pressure chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides

  • Tiia Kuuranne
  • Mikko Vahermo
  • Antti Leinonen
  • Risto Kostiainen


Mass spectrometric and tandem mass spectrometric behavior of eight anabolic steroid glucuronides were examined using electrospray (ESI) and atmospheric pressure chemical ionization (APCI) in negative and positive ion mode. The objective was to elucidate the most suitable ionization method to produce intense structure specific product ions and to examine the possibilities of distinguishing between isomeric steroid glucuronides. The analytes were glucuronide conjugates of testosterone (TG), epitestosterone (ETG), nandrolone (NG), androsterone (AG), 5α-estran-3α-ol-17-one (5α-NG), 5β-estran-3α-ol-17-one (5β-NG), 17α-methyl-5α-androstane-3α,17β-diol (5α-MTG), and 17α-methyl-5β-androstane-3α,17β-diol (5β-MTG), the last four being new compounds synthesized with enzyme-assisted method in our laboratory. High proton affinity of the 4-ene-3-one system in the steroid structure favored the formation of protonated molecule [M + H]+ in positive ion mode mass spectrometry (MS), whereas the steroid glucuronides with lower proton affinities were detected mainly as ammonium adducts [M + NH4]+. The only ion produced in negative ion mode mass spectrometry was a very intense and stable deprotonated molecule [M − H]. Positive ion ESI and APCI MS/MS spectra showed abundant and structure specific product ions [M + H − Glu]+, [M + H − Glu − H2O]+, and [M + H − Glu − 2H2O]+ of protonated molecules and corresponding ions of the ammonium adduct ions. The ratio of the relative abundances of these ions and the stability of the precursor ion provided distinction of 5α-NG and 5β-NG isomers and TG and ETG isomers. Corresponding diagnostic ions were only minor peaks in negative ion MS/MS spectra. It was shown that positive ion ESI MS/MS is the most promising method for further development of LC-MS methods for anabolic steroid glucuronides.


Proton Affinity Atmospheric Pressure Chemical Ionization Nandrolone Atmospheric Pressure Chemical Ionization Mass Spectrometry Epitestosterone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cowan, D. A.; Kicman, A. T.Clin. Chem. 1997,43, 1110–1113.Google Scholar
  2. 2.
    Celotti, F.; Negri-Cesi, P.J. Steroid Biochem. Mol. Biol. 1992,43, 469–477.CrossRefGoogle Scholar
  3. 3.
    Lamb, D. R.Am. J. Sports Medic. 1984,12, 31–38.CrossRefGoogle Scholar
  4. 4.
    Middleman, A. B.; DuRant, R. H.Sports Med. 1996,21, 251–255.CrossRefGoogle Scholar
  5. 5.
    Kuoppasalmi, K. Dissertation, Helsinki, 1981, p 40.Google Scholar
  6. 6.
    Wu, F. C. W.Clin. Chem. 1997,43, 1289–1292.Google Scholar
  7. 7.
    Schänzer, W.; Donike, M.Anal. Chim. Acta 1993,275, 23–48.CrossRefGoogle Scholar
  8. 8.
    Mulder, G. J.; Coughtrie, M. W. H.; Burchell, B. InConjugation Reactions in Drug Metabolism; Mulder, G. J., Ed.; Taylor & Francis: Great Britain, 1990; pp 52–53.Google Scholar
  9. 9.
    MacKenzie, P. I.; Rodbourne, L.; Stranks, S.J. Steroid Biochem. Mol. Biol. 1992,43, 1099–1105.CrossRefGoogle Scholar
  10. 10.
    Schänzer, W.; Delahaut, P.; Geyer, H.; Machnik, M.; Horning, S.J. Chromatogr. Sect. B 1996,678, 93–108.CrossRefGoogle Scholar
  11. 11.
    Bowers, L. D.; Sanaullah, J.Chromatogr. Sect. B 1996,687, 61–68.CrossRefGoogle Scholar
  12. 12.
    Messeri, G.; Cugnetto, G.; Moneti, G.; Serio, M.J. Steroid Biochem. 1984,20, 793–796.CrossRefGoogle Scholar
  13. 13.
    Bowers, L. D.Clin. Chem. 1997,43, 1299–1304.Google Scholar
  14. 14.
    Bean, K. A.; Henion, J. D.J. Chromatogr. Sect. B 1997,690, 65–75.CrossRefGoogle Scholar
  15. 15.
    Bowers, L. D.; Sanaullah. InProceedings of the Manfred Donike Workshop 13th Cologne Workshop on Dope Analysis; Donike, M.; Geyer, H.; Gotzmann, A.; Mareck-Engelke, U., Eds.; Sport und Buch Strauß: Cologne, 1996; pp 271–273.Google Scholar
  16. 16.
    Bowers, L. D.; Sanaullah.J. Steroid Biochem. Mol. Biol. 1996,58, 225–234.CrossRefGoogle Scholar
  17. 17.
    Conrow, R. B.; Bernstein, S.J. Organ. Chem. 1971,36, 863–870.CrossRefGoogle Scholar
  18. 18.
    Chung, B. C.; Mallamo, J. P.; Juniewicz, P. E.; Shackleton, C. H. L.Steroids 1992,57, 530–536.CrossRefGoogle Scholar
  19. 19.
    Luukkanen, L.; Kilpeläinen, I.; Kangas, H.; Ottoila, P.; Elovaara, E.; Taskinen, J.Bioconjugate Chem. 1999,10, 150–154.CrossRefGoogle Scholar
  20. 20.
    Luukkanen, L.; Elovaara, E.; Lautala, P.; Taskinen, J.; Vainio, H.Pharmacol. Toxicol. 1997,80, 152–158.CrossRefGoogle Scholar
  21. 21.
    Falany, C. N.; Green, M. D.; Swain, E.; Tephly, T. R.Biochem. J. 1986,238, 65–73.Google Scholar
  22. 22.
    Chung, L. W. K.; Coffey, D. S.Steroids 1977,30, 223–243.CrossRefGoogle Scholar
  23. 23.
    Bansal, S. K.; Gessener, T.Anal. Biochem. 1980,109, 321–329.CrossRefGoogle Scholar
  24. 24.
    Bruins, A. P.Biomed. Mass Spectrom. 1981,8, 31–35.CrossRefGoogle Scholar
  25. 25.
    Cole, R. B.; Guenat, C. R.; Gaskell, S. J.Anal. Chem. 1987,59, 1139–1144.CrossRefGoogle Scholar
  26. 26.
    Schaff, J. E.; Bowers, L. D.Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics, Orlando, FL, May 31–June 4, 1998, Abstracts, 1998; p 83.Google Scholar
  27. 27.
    Tomer, K. B.; Gross, M. L.Biomed. Environ. Mass Spectrom. 1988,15, 89–98.CrossRefGoogle Scholar
  28. 28.
    Crow, F. W.; Tomer, K. B.; Looker, J. H.; Gross, M. L.Anal. Biochem. 1986,155, 286–307.CrossRefGoogle Scholar
  29. 29.
    Tomer, K. B.; Jensen, N. J.; Gross, M. L.; Whitney, J.Biomed. Environ. Mass Spectrom. 1986,13, 265–272.CrossRefGoogle Scholar
  30. 30.
    Meng, L.-J.; Sjövall, J.J. Chromatogr. Sect. B. 1997,688, 11–26.CrossRefGoogle Scholar
  31. 31.
    Watson, D.; Taylor, G. W.; Murray, S.Biomed. Environ. Mass Spectrom. 1986,13, 65–69.CrossRefGoogle Scholar
  32. 32.
    Shinohara, Y.; Baba, S.; Kasuya, Y.Steroids 1984,44, 253–260.CrossRefGoogle Scholar
  33. 33.
    Williams, T. M.; Kind, A. J.; Houghton, E.; Hill, D. W.J. Mass Spectrom. 1999,34, 206–216.CrossRefGoogle Scholar
  34. 34.
    Harrison, A. G.Chemical Ionization Mass Spectrometry; CRC: Boca Raton, FL, 1982; p 117.Google Scholar
  35. 35.
    Dzidic, I.; McCloskey, J. A.Org. Mass Spectrom. 1972,6, 939–940.CrossRefGoogle Scholar
  36. 36.
    Dell, A. InAdvances in Carbohydrate Chemistry and Biochemistry; Tipson, R. S.; Horton, D., Ed.; Academic: CA, 1987; pp 44–45.Google Scholar

Copyright information

© American Society for Mass Spectrometry 2000

Authors and Affiliations

  • Tiia Kuuranne
    • 1
  • Mikko Vahermo
    • 1
  • Antti Leinonen
    • 2
  • Risto Kostiainen
    • 1
    • 3
  1. 1.Department of Pharmacy, Division of Pharmaceutical ChemistryUniversity of HelsinkiHelsinkiFinland
  2. 2.Doping Control LaboratoryUnited Laboratories Ltd.HelsinkiFinland
  3. 3.Viikki Drug Discovery Technology CenterUniversity of HelsinkiHelsinkiFinland

Personalised recommendations